In his role as President and Chief Operating Officer (COO) for PAREXEL, Mark Goldberg leads the company’s global management team to capitalize on the strong market opportunity for global biopharmaceutical services. He is responsible for operational oversight for all of PAREXEL’s business units.
Mark has been with PAREXEL’s executive management team for more than 19 years. In that time, he has applied his combined medical, technical, and clinical research expertise to help grow the company’s technological capabilities to advance the clinical development process.
In 2011, Mark was recognized by The Week magazine in its list of the world’s top emerging business leaders. In 2012, he received the Special Recognition Award from the Academy of Physicians in Clinical Research for advancing clinical research through a combination of medical knowledge, development expertise, and information technology.
Mark holds a degree in Computer Science and Engineering from the Massachusetts Institute of Technology (M.I.T.), and an M.D. from the University of Massachusetts Medical School.